InvestorsHub Logo
Followers 16
Posts 296
Boards Moderated 0
Alias Born 10/20/2009

Re: None

Sunday, 07/13/2014 12:12:38 AM

Sunday, July 13, 2014 12:12:38 AM

Post# of 403103
I just posted this in response to a FORBES article by Matthew Herper: How To Avert An Antibiotic Apocalypse.
http://www.forbes.com/sites/matthewherper/2014/01/27/how-to-avert-antibiotic-apocalypse/

Full disclosure: I am long Cellceutix (CTIX), a very small cap company-under $200 Million and stock price under $2.00. They have a very promising antibiotic, brilacidin, in human trials now, set to report results in a couple of months. Here’s a recent press release that explains it better than I can. CTIX also has a cancer drug in trials at Harvard’s Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center. https://finance.yahoo.com/news/cellceutix-brilacidin-absssi-trial-gets-110000777.html
This is such a small company that its under the radar and so has the potential to be a life changing investment. The several drugs in their pipeline have the potential to save lives. I’d be happy to read your comments on CTIX.
Thanks for your interesting article.
George Harvey
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News